Liraglutide and exenatide are already off-patent and semaglutide will begin losing exclusivity in several large countries from 2026 (read more in our blog Off-patent semaglutide in 2026)
But I think any potential benefits should be investigated. Dr Harshal Deshmukh, a consultant endocrinologist and senior clinical lecturer at the University of Hull, said: Excessive weight has been identified as a significant risk factor for a range of comorbidities, including fatty liver, various cancers, dementia, and cardiovascular diseases
Note: Results from natural supplements are rarely overnight
Of course, these medications arent for everybody
This, to me and to Uoma Beauty Founder Sharon Chuter, is essentially a bullsh*t hysteria industry masked as science but is largely built on marketing tactics, fear, and exclusivity